1. European Medicines Agency.Guideline on Clinical Trials in Small Populations. Adopted guideline CHMP/EWP/83561/2005. . Accessed 15 May2015.
2. U.S. Food and Drug Administration.Rare Diseases: Common Issues in Drug Development Guidance for Industry [Internet]. Center for Drug Evaluation and Research (CDER). . Accessed 12 May2016.
3. U.S. Food and Drug Administration.Targeted Drug Development: Why Are Many Diseases Lagging Behind?. Accessed 15 May2015.
4. Sasinowski F.J.Quantum of Effectiveness Evidence in FDA's Approval of Orphan Drugs. . Accessed 6 June2016.
5. Experimental designs for small randomised clinical trials: an algorithm for choice